Cargando…

Refining Lung Cancer Screening Criteria in the Era of Value-Based Medicine

In a Perspective on the Research Article by ten Haaf and colleagues, Steven Shapiro discusses the challenges of identifying screening strategies that maximize the number of cancers diagnosed, while minimizing the harms of overdiagnosis and maintaining cost-effectiveness.

Detalles Bibliográficos
Autor principal:	Shapiro, Steven D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295661/ https://www.ncbi.nlm.nih.gov/pubmed/28170392 http://dx.doi.org/10.1371/journal.pmed.1002226

Ejemplares similares

Cancer prevention and screening: the next step in the era of precision medicine
por: Loomans-Kropp, Holli A., et al.
Publicado: (2019)

Medical futility in the era of evidence-based medicine
por: Jiang, Zhengyu, et al.
Publicado: (2014)

Immunotherapy in the Precision Medicine Era: Melanoma and Beyond
por: Su, Mack Y., et al.
Publicado: (2016)

Molecular and Genomic Profiling of Lung Cancer in the Era of Precision Medicine: A Position Paper from the Italian Association of Thoracic Oncology (AIOT)
por: Normanno, Nicola, et al.
Publicado: (2020)

Journey from oncologist to cancer survivor and patient advocate in the era of precision medicine
por: Needles, Burton M.
Publicado: (2018)

Refining national greenhouse gas inventories
por: Yona, Leehi, et al.
Publicado: (2020)

Microglial depletion and repopulation: a new era of regenerative medicine?
por: Barnett, Alexandra M., et al.
Publicado: (2020)

Toward refining Alzheimer's disease into overlapping subgroups
por: Hascup, Erin R., et al.
Publicado: (2020)

Systems Biology for Simulating Patient Physiology During the Postgenomic Era of Medicine
por: Schmidt, B J
Publicado: (2014)

Applications of Radiomics and Radiogenomics in High-Grade Gliomas in the Era of Precision Medicine
por: Fathi Kazerooni, Anahita, et al.
Publicado: (2021)

Therapeutic revolution for inoperable stage III non-small cell lung cancer in the immune era
por: Li, Jiakang, et al.
Publicado: (2022)

Sex, ApoE4 and Alzheimer’s disease: rethinking drug discovery in the era of precision medicine
por: Paranjpe, Manish D., et al.
Publicado: (2021)

Entering the ‘big data’ era in medicinal chemistry: molecular promiscuity analysis revisited
por: Hu, Ye, et al.
Publicado: (2017)

The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era
por: Morello, Enrico, et al.
Publicado: (2018)

Perspective: Refined Grains and Health: Genuine Risk, or Guilt by Association?
por: Gaesser, Glenn A
Publicado: (2019)

Sugar concentration in nectar: a quantitative metric of crop attractiveness for refined pollinator risk assessments
por: Knopper, Loren D, et al.
Publicado: (2016)

Artificial Intelligence Tools for Refining Lung Cancer Screening
por: Espinoza, J. Luis, et al.
Publicado: (2020)

Prostate cancer screening research can benefit from network medicine: an emerging awareness
por: Panebianco, Valeria, et al.
Publicado: (2020)

Translating genomic information into clinical medicine: Lung cancer as a paradigm
por: Levy, Mia A., et al.
Publicado: (2012)

Occupational safety and health criteria for responsible development of nanotechnology
por: Schulte, P. A., et al.
Publicado: (2013)

Seronegative antiphospholipid syndrome: refining the value of “non-criteria” antibodies for diagnosis and clinical management
por: Pignatelli, Pasquale, et al.
Publicado: (2020)

Era of hospitalists
por: Palabindala, Venkataraman, et al.
Publicado: (2018)

The Prime and Integral Cause of Cancer in the Post-Warburg Era
por: Harguindey, Salvador, et al.
Publicado: (2023)

New era: prospects for managing cancer of unknown primary
por: Li, Yize, et al.
Publicado: (2023)

The Valencia consensus-based adaptation of the IASP complex regional pain syndrome diagnostic criteria
por: Goebel, Andreas, et al.
Publicado: (2021)

Myalgic Encephalomyelitis or What? The International Consensus Criteria
por: Twisk, Frank
Publicado: (2018)

Brain Death Criteria: Medical Dogma and Outliers
por: Rayner, Molly, et al.
Publicado: (2019)

The role of precision medicine in interstitial lung disease
por: Maher, Toby M., et al.
Publicado: (2022)

Perspective: Whole and Refined Grains and Health—Evidence Supporting “Make Half Your Grains Whole”
por: Jones, Julie Miller, et al.
Publicado: (2020)

Pharmacogenomics in the era of personalised medicine
por: White, Cassandra, et al.
Publicado: (2022)

The IMPACT framework and implementation for accessible in silico clinical phenotyping in the digital era
por: Wen, Andrew, et al.
Publicado: (2023)

Real‐World Evidence in EU Medicines Regulation: Enabling Use and Establishing Value
por: Arlett, Peter, et al.
Publicado: (2021)

The reimagination of school-based physical activity research in the COVID-19 era
por: Harrington, Deirdre M., et al.
Publicado: (2020)

Weighing in on monkeypox against the criteria of public health emergency
por: Lamptey, Emmanuel
Publicado: (2023)

Enabling patients in effective self-management of breathlessness in lung cancer: the neglected pillar of personalized medicine
por: Howell, Doris
Publicado: (2021)

Surviving in the era of "Big Data"
por: Kwon, Seog-Woon
Publicado: (2013)

Lung Cancer Screening Criteria and Cardiopulmonary Comorbidities
por: Pu, Chan Yeu, et al.
Publicado: (2022)

Proteomics as a Method for Early Detection of Cancer: A Review of Proteomics, Exhaled Breath Condensate, and Lung Cancer Screening
por: Conrad, Dean H., et al.
Publicado: (2007)

Evidence Based Management of Acute Heart Failure in the Era of COVID-19 Pandemic
por: Wang, Lexin
Publicado: (2022)

The Sharing Experimental Animal Resources, Coordinating Holdings (SEARCH) Framework: Encouraging Reduction, Replacement, and Refinement in Animal Research
por: Morrissey, Bethny, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pkfc2ruibgi4ha4i5gka111dse